nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CYP19A1—Paclitaxel—kidney cancer	0.145	0.349	CbGbCtD
Danazol—CYP3A4—Everolimus—kidney cancer	0.0791	0.191	CbGbCtD
Danazol—CYP3A4—Temsirolimus—kidney cancer	0.0535	0.129	CbGbCtD
Danazol—CYP3A4—Pazopanib—kidney cancer	0.0281	0.0676	CbGbCtD
Danazol—CCL2—nephron—kidney cancer	0.0239	0.306	CbGeAlD
Danazol—CYP3A4—Erlotinib—kidney cancer	0.02	0.0483	CbGbCtD
Danazol—CYP3A4—Paclitaxel—kidney cancer	0.0183	0.0442	CbGbCtD
Danazol—CYP3A4—Sorafenib—kidney cancer	0.0163	0.0392	CbGbCtD
Danazol—CYP3A4—Vinblastine—kidney cancer	0.0161	0.0388	CbGbCtD
Danazol—CYP3A4—Vincristine—kidney cancer	0.0158	0.0381	CbGbCtD
Danazol—CYP3A4—Sunitinib—kidney cancer	0.0132	0.0318	CbGbCtD
Danazol—CYP3A4—Doxorubicin—kidney cancer	0.00989	0.0238	CbGbCtD
Danazol—GNRHR—gonad—kidney cancer	0.00539	0.0691	CbGeAlD
Danazol—CCL2—nephron tubule—kidney cancer	0.00516	0.0662	CbGeAlD
Danazol—CCL2—renal system—kidney cancer	0.00469	0.0601	CbGeAlD
Danazol—CCL2—kidney—kidney cancer	0.00453	0.0581	CbGeAlD
Danazol—CCL2—cortex of kidney—kidney cancer	0.00441	0.0566	CbGeAlD
Danazol—CYP3A4—urine—kidney cancer	0.00439	0.0564	CbGeAlD
Danazol—CCL2—cardiac atrium—kidney cancer	0.0042	0.0539	CbGeAlD
Danazol—SHBG—gonad—kidney cancer	0.00245	0.0315	CbGeAlD
Danazol—CYP19A1—gonad—kidney cancer	0.00199	0.0255	CbGeAlD
Danazol—AR—renal system—kidney cancer	0.00196	0.0252	CbGeAlD
Danazol—ESR1—renal system—kidney cancer	0.00193	0.0247	CbGeAlD
Danazol—AR—kidney—kidney cancer	0.0019	0.0243	CbGeAlD
Danazol—ESR1—kidney—kidney cancer	0.00186	0.0239	CbGeAlD
Danazol—AR—cortex of kidney—kidney cancer	0.00185	0.0237	CbGeAlD
Danazol—AR—gonad—kidney cancer	0.00176	0.0226	CbGeAlD
Danazol—AR—cardiac atrium—kidney cancer	0.00176	0.0225	CbGeAlD
Danazol—ESR1—gonad—kidney cancer	0.00173	0.0222	CbGeAlD
Danazol—Hydrocortisone—ANXA1—kidney cancer	0.00128	0.471	CrCbGaD
Danazol—CYP3A4—renal system—kidney cancer	0.00108	0.0138	CbGeAlD
Danazol—CYP3A4—kidney—kidney cancer	0.00104	0.0133	CbGeAlD
Danazol—Shock—Sunitinib—kidney cancer	0.000421	0.00138	CcSEcCtD
Danazol—Thrombocytopenia—Sunitinib—kidney cancer	0.000419	0.00137	CcSEcCtD
Danazol—Vomiting—Pazopanib—kidney cancer	0.000412	0.00135	CcSEcCtD
Danazol—Rash—Pazopanib—kidney cancer	0.000409	0.00134	CcSEcCtD
Danazol—Nausea—Temsirolimus—kidney cancer	0.000409	0.00134	CcSEcCtD
Danazol—Dermatitis—Pazopanib—kidney cancer	0.000408	0.00134	CcSEcCtD
Danazol—Back pain—Gemcitabine—kidney cancer	0.000407	0.00133	CcSEcCtD
Danazol—Haemoglobin—Paclitaxel—kidney cancer	0.000406	0.00133	CcSEcCtD
Danazol—Headache—Pazopanib—kidney cancer	0.000406	0.00133	CcSEcCtD
Danazol—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000405	0.00133	CcSEcCtD
Danazol—Oedema—Dactinomycin—kidney cancer	0.000405	0.00133	CcSEcCtD
Danazol—Body temperature increased—Everolimus—kidney cancer	0.000405	0.00133	CcSEcCtD
Danazol—Fluid retention—Doxorubicin—kidney cancer	0.000404	0.00133	CcSEcCtD
Danazol—Haemorrhage—Paclitaxel—kidney cancer	0.000404	0.00133	CcSEcCtD
Danazol—Vertigo—Vincristine—kidney cancer	0.000398	0.00131	CcSEcCtD
Danazol—Leukopenia—Vincristine—kidney cancer	0.000397	0.0013	CcSEcCtD
Danazol—Thrombocytopenia—Dactinomycin—kidney cancer	0.000396	0.0013	CcSEcCtD
Danazol—Dyspepsia—Sorafenib—kidney cancer	0.000391	0.00128	CcSEcCtD
Danazol—Body temperature increased—Erlotinib—kidney cancer	0.000391	0.00128	CcSEcCtD
Danazol—Visual impairment—Paclitaxel—kidney cancer	0.00039	0.00128	CcSEcCtD
Danazol—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00039	0.00128	CcSEcCtD
Danazol—Nausea—Pazopanib—kidney cancer	0.000385	0.00126	CcSEcCtD
Danazol—Paraesthesia—Sunitinib—kidney cancer	0.000384	0.00126	CcSEcCtD
Danazol—Convulsion—Vincristine—kidney cancer	0.000384	0.00126	CcSEcCtD
Danazol—Fatigue—Sorafenib—kidney cancer	0.000383	0.00126	CcSEcCtD
Danazol—Hypertension—Vincristine—kidney cancer	0.000383	0.00125	CcSEcCtD
Danazol—Erythema multiforme—Paclitaxel—kidney cancer	0.000382	0.00125	CcSEcCtD
Danazol—Constipation—Sorafenib—kidney cancer	0.00038	0.00125	CcSEcCtD
Danazol—Photosensitivity reaction—Capecitabine—kidney cancer	0.000378	0.00124	CcSEcCtD
Danazol—Weight increased—Capecitabine—kidney cancer	0.000377	0.00124	CcSEcCtD
Danazol—Dyspepsia—Sunitinib—kidney cancer	0.000376	0.00123	CcSEcCtD
Danazol—Leukopenia—Gemcitabine—kidney cancer	0.000376	0.00123	CcSEcCtD
Danazol—Flushing—Paclitaxel—kidney cancer	0.000375	0.00123	CcSEcCtD
Danazol—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000369	0.00121	CcSEcCtD
Danazol—Asthenia—Vinblastine—kidney cancer	0.000369	0.00121	CcSEcCtD
Danazol—Fatigue—Sunitinib—kidney cancer	0.000369	0.00121	CcSEcCtD
Danazol—Asthenia—Everolimus—kidney cancer	0.000367	0.0012	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000366	0.0012	CcSEcCtD
Danazol—Constipation—Sunitinib—kidney cancer	0.000366	0.0012	CcSEcCtD
Danazol—Acute coronary syndrome—Capecitabine—kidney cancer	0.000364	0.00119	CcSEcCtD
Danazol—Hypertension—Gemcitabine—kidney cancer	0.000363	0.00119	CcSEcCtD
Danazol—Chills—Paclitaxel—kidney cancer	0.000363	0.00119	CcSEcCtD
Danazol—Myocardial infarction—Capecitabine—kidney cancer	0.000362	0.00119	CcSEcCtD
Danazol—Pruritus—Everolimus—kidney cancer	0.000362	0.00119	CcSEcCtD
Danazol—Oedema—Vincristine—kidney cancer	0.000362	0.00119	CcSEcCtD
Danazol—Jaundice—Capecitabine—kidney cancer	0.00036	0.00118	CcSEcCtD
Danazol—Arthralgia—Gemcitabine—kidney cancer	0.000358	0.00117	CcSEcCtD
Danazol—Alopecia—Paclitaxel—kidney cancer	0.000357	0.00117	CcSEcCtD
Danazol—Asthenia—Erlotinib—kidney cancer	0.000354	0.00116	CcSEcCtD
Danazol—Thrombocytopenia—Vincristine—kidney cancer	0.000354	0.00116	CcSEcCtD
Danazol—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000354	0.00116	CcSEcCtD
Danazol—Urticaria—Sorafenib—kidney cancer	0.000353	0.00116	CcSEcCtD
Danazol—Haematuria—Capecitabine—kidney cancer	0.000352	0.00116	CcSEcCtD
Danazol—Photosensitivity—Doxorubicin—kidney cancer	0.000352	0.00115	CcSEcCtD
Danazol—Body temperature increased—Sorafenib—kidney cancer	0.000351	0.00115	CcSEcCtD
Danazol—Hyperhidrosis—Vincristine—kidney cancer	0.00035	0.00115	CcSEcCtD
Danazol—Pruritus—Erlotinib—kidney cancer	0.000349	0.00115	CcSEcCtD
Danazol—Fatigue—Dactinomycin—kidney cancer	0.000349	0.00114	CcSEcCtD
Danazol—Tension—Paclitaxel—kidney cancer	0.000345	0.00113	CcSEcCtD
Danazol—Oedema—Gemcitabine—kidney cancer	0.000343	0.00113	CcSEcCtD
Danazol—Nervousness—Paclitaxel—kidney cancer	0.000342	0.00112	CcSEcCtD
Danazol—Back pain—Paclitaxel—kidney cancer	0.00034	0.00112	CcSEcCtD
Danazol—Dizziness—Vinblastine—kidney cancer	0.00034	0.00111	CcSEcCtD
Danazol—Dizziness—Everolimus—kidney cancer	0.000339	0.00111	CcSEcCtD
Danazol—Muscle spasms—Paclitaxel—kidney cancer	0.000338	0.00111	CcSEcCtD
Danazol—Body temperature increased—Sunitinib—kidney cancer	0.000338	0.00111	CcSEcCtD
Danazol—Thrombocytopenia—Gemcitabine—kidney cancer	0.000336	0.0011	CcSEcCtD
Danazol—Haemoglobin—Capecitabine—kidney cancer	0.000334	0.00109	CcSEcCtD
Danazol—Haemorrhage—Capecitabine—kidney cancer	0.000332	0.00109	CcSEcCtD
Danazol—Vision blurred—Paclitaxel—kidney cancer	0.000332	0.00109	CcSEcCtD
Danazol—Hyperhidrosis—Gemcitabine—kidney cancer	0.000332	0.00109	CcSEcCtD
Danazol—Tremor—Paclitaxel—kidney cancer	0.00033	0.00108	CcSEcCtD
Danazol—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00033	0.00108	CcSEcCtD
Danazol—Vomiting—Vinblastine—kidney cancer	0.000327	0.00107	CcSEcCtD
Danazol—Dizziness—Erlotinib—kidney cancer	0.000327	0.00107	CcSEcCtD
Danazol—Vomiting—Everolimus—kidney cancer	0.000326	0.00107	CcSEcCtD
Danazol—Paraesthesia—Vincristine—kidney cancer	0.000325	0.00106	CcSEcCtD
Danazol—Rash—Everolimus—kidney cancer	0.000323	0.00106	CcSEcCtD
Danazol—Dermatitis—Everolimus—kidney cancer	0.000323	0.00106	CcSEcCtD
Danazol—Headache—Vinblastine—kidney cancer	0.000322	0.00106	CcSEcCtD
Danazol—Headache—Everolimus—kidney cancer	0.000321	0.00105	CcSEcCtD
Danazol—Body temperature increased—Dactinomycin—kidney cancer	0.00032	0.00105	CcSEcCtD
Danazol—Visual impairment—Capecitabine—kidney cancer	0.00032	0.00105	CcSEcCtD
Danazol—Asthenia—Sorafenib—kidney cancer	0.000319	0.00105	CcSEcCtD
Danazol—Vertigo—Paclitaxel—kidney cancer	0.000316	0.00104	CcSEcCtD
Danazol—Syncope—Paclitaxel—kidney cancer	0.000316	0.00103	CcSEcCtD
Danazol—Leukopenia—Paclitaxel—kidney cancer	0.000315	0.00103	CcSEcCtD
Danazol—Pruritus—Sorafenib—kidney cancer	0.000314	0.00103	CcSEcCtD
Danazol—Vomiting—Erlotinib—kidney cancer	0.000314	0.00103	CcSEcCtD
Danazol—Erythema multiforme—Capecitabine—kidney cancer	0.000314	0.00103	CcSEcCtD
Danazol—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000313	0.00102	CcSEcCtD
Danazol—Fatigue—Vincristine—kidney cancer	0.000312	0.00102	CcSEcCtD
Danazol—Rash—Erlotinib—kidney cancer	0.000311	0.00102	CcSEcCtD
Danazol—Dermatitis—Erlotinib—kidney cancer	0.000311	0.00102	CcSEcCtD
Danazol—Palpitations—Paclitaxel—kidney cancer	0.000311	0.00102	CcSEcCtD
Danazol—Headache—Erlotinib—kidney cancer	0.000309	0.00101	CcSEcCtD
Danazol—Loss of consciousness—Paclitaxel—kidney cancer	0.000309	0.00101	CcSEcCtD
Danazol—Constipation—Vincristine—kidney cancer	0.000309	0.00101	CcSEcCtD
Danazol—Paraesthesia—Gemcitabine—kidney cancer	0.000308	0.00101	CcSEcCtD
Danazol—Flushing—Capecitabine—kidney cancer	0.000308	0.00101	CcSEcCtD
Danazol—Asthenia—Sunitinib—kidney cancer	0.000307	0.00101	CcSEcCtD
Danazol—Nausea—Vinblastine—kidney cancer	0.000305	0.001	CcSEcCtD
Danazol—Convulsion—Paclitaxel—kidney cancer	0.000305	0.001	CcSEcCtD
Danazol—Affect lability—Doxorubicin—kidney cancer	0.000304	0.000998	CcSEcCtD
Danazol—Migraine—Doxorubicin—kidney cancer	0.000304	0.000998	CcSEcCtD
Danazol—Nausea—Everolimus—kidney cancer	0.000304	0.000997	CcSEcCtD
Danazol—Hypertension—Paclitaxel—kidney cancer	0.000304	0.000996	CcSEcCtD
Danazol—Pruritus—Sunitinib—kidney cancer	0.000303	0.000992	CcSEcCtD
Danazol—Arthralgia—Paclitaxel—kidney cancer	0.0003	0.000983	CcSEcCtD
Danazol—Anxiety—Paclitaxel—kidney cancer	0.000299	0.000979	CcSEcCtD
Danazol—Chills—Capecitabine—kidney cancer	0.000298	0.000976	CcSEcCtD
Danazol—Fatigue—Gemcitabine—kidney cancer	0.000296	0.00097	CcSEcCtD
Danazol—Dizziness—Sorafenib—kidney cancer	0.000294	0.000964	CcSEcCtD
Danazol—Constipation—Gemcitabine—kidney cancer	0.000293	0.000962	CcSEcCtD
Danazol—Nausea—Erlotinib—kidney cancer	0.000293	0.000962	CcSEcCtD
Danazol—Alopecia—Capecitabine—kidney cancer	0.000293	0.000961	CcSEcCtD
Danazol—Mood swings—Doxorubicin—kidney cancer	0.000293	0.00096	CcSEcCtD
Danazol—Asthenia—Dactinomycin—kidney cancer	0.00029	0.000952	CcSEcCtD
Danazol—Oedema—Paclitaxel—kidney cancer	0.000287	0.000942	CcSEcCtD
Danazol—Body temperature increased—Vincristine—kidney cancer	0.000286	0.000937	CcSEcCtD
Danazol—Dizziness—Sunitinib—kidney cancer	0.000283	0.000927	CcSEcCtD
Danazol—Shock—Paclitaxel—kidney cancer	0.000283	0.000927	CcSEcCtD
Danazol—Vomiting—Sorafenib—kidney cancer	0.000283	0.000926	CcSEcCtD
Danazol—Abdominal pain upper—Doxorubicin—kidney cancer	0.000282	0.000926	CcSEcCtD
Danazol—Thrombocytopenia—Paclitaxel—kidney cancer	0.000281	0.000922	CcSEcCtD
Danazol—Tachycardia—Paclitaxel—kidney cancer	0.00028	0.000919	CcSEcCtD
Danazol—Rash—Sorafenib—kidney cancer	0.00028	0.000919	CcSEcCtD
Danazol—Dermatitis—Sorafenib—kidney cancer	0.00028	0.000918	CcSEcCtD
Danazol—Back pain—Capecitabine—kidney cancer	0.000279	0.000916	CcSEcCtD
Danazol—Headache—Sorafenib—kidney cancer	0.000278	0.000913	CcSEcCtD
Danazol—Muscle spasms—Capecitabine—kidney cancer	0.000278	0.000911	CcSEcCtD
Danazol—Hyperhidrosis—Paclitaxel—kidney cancer	0.000278	0.000911	CcSEcCtD
Danazol—Vision blurred—Capecitabine—kidney cancer	0.000272	0.000893	CcSEcCtD
Danazol—Vomiting—Sunitinib—kidney cancer	0.000272	0.000891	CcSEcCtD
Danazol—Body temperature increased—Gemcitabine—kidney cancer	0.000271	0.000889	CcSEcCtD
Danazol—Tremor—Capecitabine—kidney cancer	0.000271	0.000887	CcSEcCtD
Danazol—Rash—Sunitinib—kidney cancer	0.00027	0.000884	CcSEcCtD
Danazol—Dermatitis—Sunitinib—kidney cancer	0.000269	0.000883	CcSEcCtD
Danazol—Headache—Sunitinib—kidney cancer	0.000268	0.000878	CcSEcCtD
Danazol—Eosinophilia—Doxorubicin—kidney cancer	0.000265	0.000868	CcSEcCtD
Danazol—Nausea—Sorafenib—kidney cancer	0.000264	0.000866	CcSEcCtD
Danazol—Pancreatitis—Doxorubicin—kidney cancer	0.000262	0.000859	CcSEcCtD
Danazol—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000262	0.000858	CcSEcCtD
Danazol—Vertigo—Capecitabine—kidney cancer	0.00026	0.000851	CcSEcCtD
Danazol—Asthenia—Vincristine—kidney cancer	0.00026	0.000851	CcSEcCtD
Danazol—Syncope—Capecitabine—kidney cancer	0.000259	0.000849	CcSEcCtD
Danazol—Leukopenia—Capecitabine—kidney cancer	0.000259	0.000848	CcSEcCtD
Danazol—Paraesthesia—Paclitaxel—kidney cancer	0.000258	0.000846	CcSEcCtD
Danazol—Vomiting—Dactinomycin—kidney cancer	0.000257	0.000844	CcSEcCtD
Danazol—Palpitations—Capecitabine—kidney cancer	0.000255	0.000837	CcSEcCtD
Danazol—Rash—Dactinomycin—kidney cancer	0.000255	0.000837	CcSEcCtD
Danazol—Nausea—Sunitinib—kidney cancer	0.000254	0.000833	CcSEcCtD
Danazol—Loss of consciousness—Capecitabine—kidney cancer	0.000254	0.000832	CcSEcCtD
Danazol—Dyspepsia—Paclitaxel—kidney cancer	0.000253	0.000829	CcSEcCtD
Danazol—Hypertension—Capecitabine—kidney cancer	0.000249	0.000818	CcSEcCtD
Danazol—Fatigue—Paclitaxel—kidney cancer	0.000248	0.000812	CcSEcCtD
Danazol—Asthenia—Gemcitabine—kidney cancer	0.000246	0.000807	CcSEcCtD
Danazol—Arthralgia—Capecitabine—kidney cancer	0.000246	0.000806	CcSEcCtD
Danazol—Constipation—Paclitaxel—kidney cancer	0.000246	0.000805	CcSEcCtD
Danazol—Anxiety—Capecitabine—kidney cancer	0.000245	0.000804	CcSEcCtD
Danazol—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000244	0.0008	CcSEcCtD
Danazol—Weight increased—Doxorubicin—kidney cancer	0.000243	0.000797	CcSEcCtD
Danazol—Pruritus—Gemcitabine—kidney cancer	0.000243	0.000796	CcSEcCtD
Danazol—Nausea—Dactinomycin—kidney cancer	0.00024	0.000788	CcSEcCtD
Danazol—Dizziness—Vincristine—kidney cancer	0.000239	0.000784	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000236	0.000775	CcSEcCtD
Danazol—Oedema—Capecitabine—kidney cancer	0.000236	0.000773	CcSEcCtD
Danazol—Jaundice—Doxorubicin—kidney cancer	0.000232	0.000762	CcSEcCtD
Danazol—Shock—Capecitabine—kidney cancer	0.000232	0.00076	CcSEcCtD
Danazol—Thrombocytopenia—Capecitabine—kidney cancer	0.000231	0.000757	CcSEcCtD
Danazol—Tachycardia—Capecitabine—kidney cancer	0.00023	0.000754	CcSEcCtD
Danazol—Vomiting—Vincristine—kidney cancer	0.00023	0.000754	CcSEcCtD
Danazol—Sweating—Doxorubicin—kidney cancer	0.000228	0.000749	CcSEcCtD
Danazol—Urticaria—Paclitaxel—kidney cancer	0.000228	0.000748	CcSEcCtD
Danazol—Rash—Vincristine—kidney cancer	0.000228	0.000748	CcSEcCtD
Danazol—Hyperhidrosis—Capecitabine—kidney cancer	0.000228	0.000747	CcSEcCtD
Danazol—Dermatitis—Vincristine—kidney cancer	0.000228	0.000747	CcSEcCtD
Danazol—Haematuria—Doxorubicin—kidney cancer	0.000227	0.000745	CcSEcCtD
Danazol—Body temperature increased—Paclitaxel—kidney cancer	0.000227	0.000745	CcSEcCtD
Danazol—Headache—Vincristine—kidney cancer	0.000227	0.000743	CcSEcCtD
Danazol—Progesterone—CYP1A1—kidney cancer	0.000224	0.0825	CrCbGaD
Danazol—Vomiting—Gemcitabine—kidney cancer	0.000218	0.000715	CcSEcCtD
Danazol—Rash—Gemcitabine—kidney cancer	0.000216	0.000709	CcSEcCtD
Danazol—Dermatitis—Gemcitabine—kidney cancer	0.000216	0.000709	CcSEcCtD
Danazol—Haemoglobin—Doxorubicin—kidney cancer	0.000215	0.000705	CcSEcCtD
Danazol—Headache—Gemcitabine—kidney cancer	0.000215	0.000705	CcSEcCtD
Danazol—Nausea—Vincristine—kidney cancer	0.000215	0.000704	CcSEcCtD
Danazol—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000215	0.000704	CcSEcCtD
Danazol—Haemorrhage—Doxorubicin—kidney cancer	0.000214	0.000701	CcSEcCtD
Danazol—Ethinyl Estradiol—ABCB1—kidney cancer	0.000213	0.0782	CrCbGaD
Danazol—Testosterone—CYP1A1—kidney cancer	0.000212	0.078	CrCbGaD
Danazol—Paraesthesia—Capecitabine—kidney cancer	0.000212	0.000694	CcSEcCtD
Danazol—Dyspepsia—Capecitabine—kidney cancer	0.000208	0.00068	CcSEcCtD
Danazol—Prednisone—ABCB1—kidney cancer	0.000207	0.0763	CrCbGaD
Danazol—Visual impairment—Doxorubicin—kidney cancer	0.000206	0.000676	CcSEcCtD
Danazol—Asthenia—Paclitaxel—kidney cancer	0.000206	0.000676	CcSEcCtD
Danazol—Norethindrone—ABCB1—kidney cancer	0.000204	0.0752	CrCbGaD
Danazol—Nausea—Gemcitabine—kidney cancer	0.000204	0.000668	CcSEcCtD
Danazol—Fatigue—Capecitabine—kidney cancer	0.000203	0.000666	CcSEcCtD
Danazol—Pruritus—Paclitaxel—kidney cancer	0.000203	0.000666	CcSEcCtD
Danazol—Erythema multiforme—Doxorubicin—kidney cancer	0.000202	0.000663	CcSEcCtD
Danazol—Constipation—Capecitabine—kidney cancer	0.000202	0.000661	CcSEcCtD
Danazol—Flushing—Doxorubicin—kidney cancer	0.000199	0.000651	CcSEcCtD
Danazol—Chills—Doxorubicin—kidney cancer	0.000192	0.000629	CcSEcCtD
Danazol—Dizziness—Paclitaxel—kidney cancer	0.00019	0.000623	CcSEcCtD
Danazol—Alopecia—Doxorubicin—kidney cancer	0.000189	0.00062	CcSEcCtD
Danazol—Urticaria—Capecitabine—kidney cancer	0.000187	0.000614	CcSEcCtD
Danazol—Body temperature increased—Capecitabine—kidney cancer	0.000186	0.000611	CcSEcCtD
Danazol—Tension—Doxorubicin—kidney cancer	0.000183	0.000599	CcSEcCtD
Danazol—Vomiting—Paclitaxel—kidney cancer	0.000183	0.000599	CcSEcCtD
Danazol—Rash—Paclitaxel—kidney cancer	0.000181	0.000594	CcSEcCtD
Danazol—Dermatitis—Paclitaxel—kidney cancer	0.000181	0.000593	CcSEcCtD
Danazol—Nervousness—Doxorubicin—kidney cancer	0.000181	0.000593	CcSEcCtD
Danazol—Back pain—Doxorubicin—kidney cancer	0.00018	0.000591	CcSEcCtD
Danazol—Headache—Paclitaxel—kidney cancer	0.00018	0.00059	CcSEcCtD
Danazol—Muscle spasms—Doxorubicin—kidney cancer	0.000179	0.000587	CcSEcCtD
Danazol—Vision blurred—Doxorubicin—kidney cancer	0.000175	0.000575	CcSEcCtD
Danazol—Nausea—Paclitaxel—kidney cancer	0.000171	0.000559	CcSEcCtD
Danazol—Asthenia—Capecitabine—kidney cancer	0.000169	0.000555	CcSEcCtD
Danazol—Vertigo—Doxorubicin—kidney cancer	0.000167	0.000549	CcSEcCtD
Danazol—Syncope—Doxorubicin—kidney cancer	0.000167	0.000547	CcSEcCtD
Danazol—Pruritus—Capecitabine—kidney cancer	0.000167	0.000547	CcSEcCtD
Danazol—Leukopenia—Doxorubicin—kidney cancer	0.000167	0.000546	CcSEcCtD
Danazol—Palpitations—Doxorubicin—kidney cancer	0.000165	0.00054	CcSEcCtD
Danazol—Loss of consciousness—Doxorubicin—kidney cancer	0.000164	0.000537	CcSEcCtD
Danazol—Convulsion—Doxorubicin—kidney cancer	0.000161	0.000529	CcSEcCtD
Danazol—Hypertension—Doxorubicin—kidney cancer	0.000161	0.000527	CcSEcCtD
Danazol—Arthralgia—Doxorubicin—kidney cancer	0.000159	0.00052	CcSEcCtD
Danazol—Anxiety—Doxorubicin—kidney cancer	0.000158	0.000518	CcSEcCtD
Danazol—Dizziness—Capecitabine—kidney cancer	0.000156	0.000511	CcSEcCtD
Danazol—Oedema—Doxorubicin—kidney cancer	0.000152	0.000498	CcSEcCtD
Danazol—Vomiting—Capecitabine—kidney cancer	0.00015	0.000491	CcSEcCtD
Danazol—Shock—Doxorubicin—kidney cancer	0.00015	0.00049	CcSEcCtD
Danazol—Thrombocytopenia—Doxorubicin—kidney cancer	0.000149	0.000488	CcSEcCtD
Danazol—Rash—Capecitabine—kidney cancer	0.000149	0.000487	CcSEcCtD
Danazol—Dermatitis—Capecitabine—kidney cancer	0.000149	0.000487	CcSEcCtD
Danazol—Tachycardia—Doxorubicin—kidney cancer	0.000148	0.000486	CcSEcCtD
Danazol—Headache—Capecitabine—kidney cancer	0.000148	0.000484	CcSEcCtD
Danazol—Hyperhidrosis—Doxorubicin—kidney cancer	0.000147	0.000482	CcSEcCtD
Danazol—Hydrocortisone—ABCB1—kidney cancer	0.000146	0.0538	CrCbGaD
Danazol—Nausea—Capecitabine—kidney cancer	0.00014	0.000459	CcSEcCtD
Danazol—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000138	0.000454	CcSEcCtD
Danazol—Paraesthesia—Doxorubicin—kidney cancer	0.000136	0.000447	CcSEcCtD
Danazol—Dyspepsia—Doxorubicin—kidney cancer	0.000134	0.000439	CcSEcCtD
Danazol—Fatigue—Doxorubicin—kidney cancer	0.000131	0.00043	CcSEcCtD
Danazol—Constipation—Doxorubicin—kidney cancer	0.00013	0.000426	CcSEcCtD
Danazol—Urticaria—Doxorubicin—kidney cancer	0.000121	0.000396	CcSEcCtD
Danazol—Body temperature increased—Doxorubicin—kidney cancer	0.00012	0.000394	CcSEcCtD
Danazol—Progesterone—ABCB1—kidney cancer	0.000119	0.0438	CrCbGaD
Danazol—Testosterone—ABCB1—kidney cancer	0.000113	0.0414	CrCbGaD
Danazol—Asthenia—Doxorubicin—kidney cancer	0.000109	0.000357	CcSEcCtD
Danazol—Pruritus—Doxorubicin—kidney cancer	0.000108	0.000353	CcSEcCtD
Danazol—Dizziness—Doxorubicin—kidney cancer	0.0001	0.000329	CcSEcCtD
Danazol—Vomiting—Doxorubicin—kidney cancer	9.66e-05	0.000317	CcSEcCtD
Danazol—Rash—Doxorubicin—kidney cancer	9.58e-05	0.000314	CcSEcCtD
Danazol—Dermatitis—Doxorubicin—kidney cancer	9.57e-05	0.000314	CcSEcCtD
Danazol—Headache—Doxorubicin—kidney cancer	9.52e-05	0.000312	CcSEcCtD
Danazol—Nausea—Doxorubicin—kidney cancer	9.03e-05	0.000296	CcSEcCtD
Danazol—CCL2—Signaling Pathways—CDKN2B—kidney cancer	6.12e-05	0.000307	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	6.1e-05	0.000306	CbGpPWpGaD
Danazol—AR—Gene Expression—HSPB1—kidney cancer	6.09e-05	0.000306	CbGpPWpGaD
Danazol—AR—Gene Expression—EIF4EBP1—kidney cancer	6.09e-05	0.000306	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—MAPK1—kidney cancer	6.06e-05	0.000305	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.96e-05	0.000299	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IGF1R—kidney cancer	5.94e-05	0.000299	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GPC3—kidney cancer	5.81e-05	0.000292	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CER1—kidney cancer	5.81e-05	0.000292	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ITPR2—kidney cancer	5.76e-05	0.00029	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	5.76e-05	0.000289	CbGpPWpGaD
Danazol—ESR1—Gene Expression—RPL14—kidney cancer	5.75e-05	0.000289	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—KRAS—kidney cancer	5.73e-05	0.000288	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—RAF1—kidney cancer	5.73e-05	0.000288	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CA9—kidney cancer	5.72e-05	0.000287	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—kidney cancer	5.72e-05	0.000287	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	5.69e-05	0.000286	CbGpPWpGaD
Danazol—AR—Gene Expression—PSMD7—kidney cancer	5.66e-05	0.000284	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF2—kidney cancer	5.62e-05	0.000282	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	5.61e-05	0.000282	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN2B—kidney cancer	5.6e-05	0.000281	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.59e-05	0.000281	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	5.5e-05	0.000276	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF1R—kidney cancer	5.44e-05	0.000273	CbGpPWpGaD
Danazol—PGR—Gene Expression—CDKN2B—kidney cancer	5.43e-05	0.000273	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	5.31e-05	0.000267	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—PIK3CA—kidney cancer	5.26e-05	0.000264	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—RAF1—kidney cancer	5.24e-05	0.000263	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CTNNA1—kidney cancer	5.23e-05	0.000262	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EIF4EBP1—kidney cancer	5.2e-05	0.000261	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HSPB1—kidney cancer	5.2e-05	0.000261	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—IL2—kidney cancer	5.17e-05	0.00026	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	5.16e-05	0.000259	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL2—kidney cancer	5.13e-05	0.000258	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—kidney cancer	5.12e-05	0.000257	CbGpPWpGaD
Danazol—AR—Gene Expression—JUNB—kidney cancer	5.08e-05	0.000255	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	5.05e-05	0.000254	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SFRP2—kidney cancer	4.94e-05	0.000248	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HIF1A—kidney cancer	4.89e-05	0.000246	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TSC2—kidney cancer	4.88e-05	0.000245	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTP1—kidney cancer	4.87e-05	0.000245	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CRABP1—kidney cancer	4.86e-05	0.000244	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ANXA1—kidney cancer	4.83e-05	0.000243	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TSC1—kidney cancer	4.83e-05	0.000243	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PSMD7—kidney cancer	4.83e-05	0.000243	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	4.81e-05	0.000241	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.77e-05	0.00024	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL2—kidney cancer	4.7e-05	0.000236	CbGpPWpGaD
Danazol—ESR1—Gene Expression—EIF4EBP1—kidney cancer	4.69e-05	0.000236	CbGpPWpGaD
Danazol—ESR1—Gene Expression—HSPB1—kidney cancer	4.69e-05	0.000236	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KDR—kidney cancer	4.68e-05	0.000235	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FLT1—kidney cancer	4.68e-05	0.000235	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ITPR2—kidney cancer	4.52e-05	0.000227	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTM1—kidney cancer	4.48e-05	0.000225	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HIF1A—kidney cancer	4.47e-05	0.000225	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TSC2—kidney cancer	4.46e-05	0.000224	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	4.42e-05	0.000222	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	4.38e-05	0.00022	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—MYC—kidney cancer	4.37e-05	0.000219	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PSMD7—kidney cancer	4.36e-05	0.000219	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JUNB—kidney cancer	4.34e-05	0.000218	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PAK1—kidney cancer	4.34e-05	0.000218	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KIT—kidney cancer	4.31e-05	0.000217	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APC—kidney cancer	4.31e-05	0.000217	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KDR—kidney cancer	4.28e-05	0.000215	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	4.25e-05	0.000213	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.24e-05	0.000213	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	4.19e-05	0.00021	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.17e-05	0.000209	CbGpPWpGaD
Danazol—AR—Gene Expression—CDKN2B—kidney cancer	4.14e-05	0.000208	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—MAPK3—kidney cancer	4.13e-05	0.000207	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTT1—kidney cancer	4.12e-05	0.000207	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ACHE—kidney cancer	4.12e-05	0.000207	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—POMC—kidney cancer	4.1e-05	0.000206	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—BRAF—kidney cancer	4.05e-05	0.000204	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP2—kidney cancer	3.98e-05	0.0002	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKAP13—kidney cancer	3.98e-05	0.0002	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APC—kidney cancer	3.94e-05	0.000198	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KIT—kidney cancer	3.94e-05	0.000198	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—MAPK1—kidney cancer	3.93e-05	0.000197	CbGpPWpGaD
Danazol—ESR1—Gene Expression—JUNB—kidney cancer	3.91e-05	0.000197	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SCARB1—kidney cancer	3.9e-05	0.000196	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS1—kidney cancer	3.86e-05	0.000194	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PSMD7—kidney cancer	3.79e-05	0.00019	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—MAPK3—kidney cancer	3.78e-05	0.00019	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—POMC—kidney cancer	3.75e-05	0.000188	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACY1—kidney cancer	3.74e-05	0.000188	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—KRAS—kidney cancer	3.71e-05	0.000186	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—BRAF—kidney cancer	3.71e-05	0.000186	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GRB7—kidney cancer	3.64e-05	0.000183	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—MAPK1—kidney cancer	3.59e-05	0.00018	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—BCHE—kidney cancer	3.59e-05	0.00018	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SLC5A5—kidney cancer	3.55e-05	0.000178	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF2—kidney cancer	3.55e-05	0.000178	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN2B—kidney cancer	3.53e-05	0.000177	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—PIK3CA—kidney cancer	3.43e-05	0.000172	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1R—kidney cancer	3.43e-05	0.000172	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SLC2A1—kidney cancer	3.42e-05	0.000172	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PIK3CA—kidney cancer	3.41e-05	0.000171	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—KRAS—kidney cancer	3.39e-05	0.00017	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ITPR2—kidney cancer	3.38e-05	0.00017	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RAF1—kidney cancer	3.38e-05	0.00017	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RELA—kidney cancer	3.37e-05	0.000169	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ERBB2—kidney cancer	3.35e-05	0.000168	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—MYC—kidney cancer	3.33e-05	0.000167	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.32e-05	0.000167	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MTOR—kidney cancer	3.3e-05	0.000166	CbGpPWpGaD
Danazol—ESR1—Gene Expression—CDKN2B—kidney cancer	3.19e-05	0.00016	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PDHB—kidney cancer	3.18e-05	0.00016	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—POMC—kidney cancer	3.17e-05	0.000159	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PIK3CA—kidney cancer	3.12e-05	0.000157	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CDKN1B—kidney cancer	3.1e-05	0.000156	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RAF1—kidney cancer	3.09e-05	0.000155	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RELA—kidney cancer	3.08e-05	0.000155	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CTNNA1—kidney cancer	3.07e-05	0.000154	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ERBB2—kidney cancer	3.06e-05	0.000154	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EIF4EBP1—kidney cancer	3.05e-05	0.000153	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HSPB1—kidney cancer	3.05e-05	0.000153	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL2—kidney cancer	3.03e-05	0.000152	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MTOR—kidney cancer	3.02e-05	0.000152	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CCBL1—kidney cancer	2.99e-05	0.00015	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCND1—kidney cancer	2.96e-05	0.000149	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—JUN—kidney cancer	2.95e-05	0.000148	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CTNNB1—kidney cancer	2.93e-05	0.000147	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.9e-05	0.000146	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTP1—kidney cancer	2.86e-05	0.000143	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTEN—kidney cancer	2.85e-05	0.000143	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PSMD7—kidney cancer	2.83e-05	0.000142	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ANXA1—kidney cancer	2.83e-05	0.000142	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN1B—kidney cancer	2.83e-05	0.000142	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TSC1—kidney cancer	2.83e-05	0.000142	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HIF1A—kidney cancer	2.82e-05	0.000142	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TSC2—kidney cancer	2.81e-05	0.000141	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL2—kidney cancer	2.77e-05	0.000139	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FLT1—kidney cancer	2.75e-05	0.000138	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCND1—kidney cancer	2.7e-05	0.000136	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ABCB1—kidney cancer	2.7e-05	0.000136	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KDR—kidney cancer	2.7e-05	0.000136	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—JUN—kidney cancer	2.7e-05	0.000136	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CTNNB1—kidney cancer	2.68e-05	0.000135	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTM1—kidney cancer	2.63e-05	0.000132	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTEN—kidney cancer	2.61e-05	0.000131	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPAT—kidney cancer	2.59e-05	0.00013	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.59e-05	0.00013	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—kidney cancer	2.58e-05	0.000129	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—kidney cancer	2.56e-05	0.000129	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PAK1—kidney cancer	2.55e-05	0.000128	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JUNB—kidney cancer	2.55e-05	0.000128	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP1A1—kidney cancer	2.49e-05	0.000125	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KIT—kidney cancer	2.49e-05	0.000125	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APC—kidney cancer	2.49e-05	0.000125	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK3—kidney cancer	2.44e-05	0.000122	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—FH—kidney cancer	2.41e-05	0.000121	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APRT—kidney cancer	2.41e-05	0.000121	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—kidney cancer	2.37e-05	0.000119	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—POMC—kidney cancer	2.37e-05	0.000119	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—kidney cancer	2.36e-05	0.000118	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—BRAF—kidney cancer	2.34e-05	0.000117	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK1—kidney cancer	2.32e-05	0.000117	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GPC3—kidney cancer	2.26e-05	0.000114	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK3—kidney cancer	2.23e-05	0.000112	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA2—kidney cancer	2.2e-05	0.000111	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KRAS—kidney cancer	2.19e-05	0.00011	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—kidney cancer	2.17e-05	0.000109	CbGpPWpGaD
Danazol—PGR—Gene Expression—MAPK3—kidney cancer	2.16e-05	0.000109	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALAD—kidney cancer	2.15e-05	0.000108	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK1—kidney cancer	2.12e-05	0.000107	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—kidney cancer	2.1e-05	0.000106	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.09e-05	0.000105	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF2—kidney cancer	2.08e-05	0.000105	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN2B—kidney cancer	2.07e-05	0.000104	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.05e-05	0.000103	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.04e-05	0.000103	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CA—kidney cancer	2.01e-05	0.000101	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1R—kidney cancer	2.01e-05	0.000101	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KRAS—kidney cancer	2e-05	0.000101	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PGK1—kidney cancer	1.96e-05	9.86e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.96e-05	9.86e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RAF1—kidney cancer	1.95e-05	9.8e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—kidney cancer	1.95e-05	9.78e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RELA—kidney cancer	1.94e-05	9.76e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ERBB2—kidney cancer	1.93e-05	9.7e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LDHB—kidney cancer	1.92e-05	9.67e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MTOR—kidney cancer	1.9e-05	9.57e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—POMC—kidney cancer	1.86e-05	9.32e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CA—kidney cancer	1.84e-05	9.25e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1B—kidney cancer	1.79e-05	8.98e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—kidney cancer	1.78e-05	8.95e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL2—kidney cancer	1.75e-05	8.79e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCND1—kidney cancer	1.71e-05	8.57e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JUN—kidney cancer	1.7e-05	8.55e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CTNNB1—kidney cancer	1.69e-05	8.48e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA9—kidney cancer	1.67e-05	8.38e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HIF1A—kidney cancer	1.66e-05	8.32e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TSC2—kidney cancer	1.65e-05	8.3e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MAPK3—kidney cancer	1.65e-05	8.28e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTEN—kidney cancer	1.65e-05	8.27e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—kidney cancer	1.6e-05	8.05e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KDR—kidney cancer	1.58e-05	7.96e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—kidney cancer	1.49e-05	7.47e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—kidney cancer	1.48e-05	7.43e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KIT—kidney cancer	1.46e-05	7.33e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APC—kidney cancer	1.46e-05	7.33e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CRABP1—kidney cancer	1.42e-05	7.13e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK3—kidney cancer	1.41e-05	7.06e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—POMC—kidney cancer	1.39e-05	6.98e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BRAF—kidney cancer	1.37e-05	6.89e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—kidney cancer	1.37e-05	6.87e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK1—kidney cancer	1.34e-05	6.72e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ITPR2—kidney cancer	1.32e-05	6.62e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTEN—kidney cancer	1.29e-05	6.48e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MAPK3—kidney cancer	1.27e-05	6.38e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KRAS—kidney cancer	1.26e-05	6.35e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—kidney cancer	1.23e-05	6.2e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTT1—kidney cancer	1.2e-05	6.04e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACHE—kidney cancer	1.2e-05	6.04e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CA—kidney cancer	1.16e-05	5.83e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RAF1—kidney cancer	1.15e-05	5.75e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RELA—kidney cancer	1.14e-05	5.73e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SCARB1—kidney cancer	1.14e-05	5.72e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ERBB2—kidney cancer	1.13e-05	5.69e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS1—kidney cancer	1.13e-05	5.66e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—kidney cancer	1.12e-05	5.64e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MTOR—kidney cancer	1.12e-05	5.62e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PSMD7—kidney cancer	1.11e-05	5.55e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1B—kidney cancer	1.05e-05	5.27e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—BCHE—kidney cancer	1.05e-05	5.26e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.03e-05	5.2e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2—kidney cancer	1.03e-05	5.16e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCND1—kidney cancer	1e-05	5.03e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC2A1—kidney cancer	9.99e-06	5.02e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JUN—kidney cancer	9.99e-06	5.02e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CTNNB1—kidney cancer	9.91e-06	4.98e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTEN—kidney cancer	9.66e-06	4.85e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CA—kidney cancer	9.1e-06	4.57e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—kidney cancer	8.73e-06	4.38e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTP1—kidney cancer	8.34e-06	4.19e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK3—kidney cancer	8.25e-06	4.15e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—kidney cancer	8.03e-06	4.03e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCB1—kidney cancer	7.89e-06	3.96e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK1—kidney cancer	7.85e-06	3.95e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM1—kidney cancer	7.66e-06	3.85e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KRAS—kidney cancer	7.42e-06	3.73e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP1A1—kidney cancer	7.26e-06	3.65e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CA—kidney cancer	6.82e-06	3.42e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—kidney cancer	6.59e-06	3.31e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—POMC—kidney cancer	5.41e-06	2.72e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—kidney cancer	4.32e-06	2.17e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTEN—kidney cancer	3.77e-06	1.89e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.66e-06	1.33e-05	CbGpPWpGaD
